NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/13/2024
Back to search
Official data from USPTO
NOUREXAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
02/13/2024
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
03/31/2020
Registration date
02/13/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/13/2024
Last transaction
02/13/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/15/2021
First use in commerce
08/02/2021
Drawing code
4
Owner type
03
Owner location
Vienna, VA, US
Examiner
MEYERS,MORGAN LAURA
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Nour Heart, Inc.
Representatives
Jessica Connarn SINORICA LLC DBA THOUGHTS TO PAPER
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-inflammatories; Cardiovascular treatment preparations; Cardiovascular pharmaceuticals; Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachetsinjectables and pharmaceutical preparations for the treatment of cardiovascular disorders; Cardiovascular prevention preparations; Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachetsinjectables and pharmaceutical preparations for the prevention of cardiovascular disorders; Pharmaceutical preparations and substances for the treatment of aging and aging-related diseasesas well as viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalAlzheimergastrointestinalhormonaldermatologicalpsychiatricmental depression and immune system related diseases and disorders; Pharmaceutical preparations and substances for the prevention of ischemia-dependent aging and aging-related diseasesincluding musculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalAlzheimerhormonaldermatologicalpsychiatricmental depression and immune system related diseases and disorders; Neurological Pharmaceuticals; Neurological treatment preparations; Musculoskeletal Pharmaceuticals; Vascular Pharmaceuticals; Pharmaceuticals for Prevention of Ischemic Injury; Pharmaceuticals for Prevention of Disease Progression; Cellular Energy Preservation Pharmaceuticals
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/13/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/06/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/05/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/12/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/11/2023
IUAF
USE AMENDMENT FILED
12/01/2023
EISU
TEAS STATEMENT OF USE RECEIVED
12/01/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
11/29/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/29/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/29/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/29/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/14/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/19/2023
PUBO
PUBLISHED FOR OPPOSITION
09/19/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/30/2023
PBSR
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
08/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/20/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
07/10/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/27/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/17/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
03/29/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
09/17/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
02/17/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/29/2020
GNSL
LETTER OF SUSPENSION E-MAILED
06/29/2020
CNSL
SUSPENSION LETTER WRITTEN
06/29/2020
DOCK
ASSIGNED TO EXAMINER
06/20/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/07/2020
NWAP
NEW APPLICATION ENTERED
04/03/2020
Continuous trademark protection
Get notified about every new filing that threatens NOUREXAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.